Ferritin ferroxidase activity: A potent inhibitor of osteogenesis

Journal of Bone and Mineral Research

Volumn 25, Issue 1, 2010, Pages 164-172

  Zarjou, Abolfazl ^a   Jeney, Viktória ^a   Arosio, Paolo ^b   Poli, Maura ^b   Zavaczki, Erzsébet ^a   Balla, György ^c   Balla, József ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Ferritin; Ferroxidase activity; Hemochromatosis; Iron; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CERULOPLASMIN; FERRITIN; IRON; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX1;

ARTICLE; BONE DEVELOPMENT; BONE MATURATION; BONE MINERALIZATION; CALCIFICATION; DOWN REGULATION; DRUG ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OSTEOBLAST; OSTEOID; OSTEOPENIA; OSTEOPOROSIS; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS; UPREGULATION; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; APOFERRITINS; CALCIFICATION, PHYSIOLOGIC; CELL LINE; CERULOPLASMIN; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DOWN-REGULATION; FERRITINS; HUMANS; INTRACELLULAR SPACE; IRON; ORGAN SPECIFICITY; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PHOSPHATES;

EID: 77953410541     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.091002     Document Type: Article

References (40)

1. Angelopoulos NG, Goula AK, Papanikolaou G, Tolis G. Osteoporosis in HFE2 juvenile hemochromatosis: a case report and review of the literature. Osteoporosis Int. 2006;17:150-155. (Pubitemid 41798040)
2. Guggenbuhl P, Deugnier Y, Boisdet JF, et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporosis Int. 2005;16:1809-1814. (Pubitemid 41790893)
3. Schnitzler CM, Schnaid E, MacPhail AP, Mesquita JM, Robson HJ. Ascorbic acid deficiency, iron overload and alcohol abuse underlie the severe osteoporosis in black African patients with hip fractures: a bone histomorphometric study. Calcif Tissue Int. 2005;76:79-89. (Pubitemid 40684954)
4. Weinberg ED. Iron loading: a risk factor for osteoporosis. Biometals. 2006;19:633-635.
5. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275: 161-203. (Pubitemid 26248989)
6. Theil EC. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem. 1996;56: 289-315.
7. Arosio P, Adelman TG, Drysdale JW. On ferritin heterogeneity: further evidence for heteropolymers. J Biol Chem. 1978;253:4451-4458. (Pubitemid 8384141)
8. Rucker P, Torti FM, Torti SV. Role of H and L subunits in mouse ferritin. J Biol Chem. 1996;271:33352-33357.
9. Hentze MW, Rouault TA, Caughman SW, Dancis A, Harford JB, Klausner RD. A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron. Proc Natl Acad Sci USA. 1987;84:6730-6734. (Pubitemid 18032473)
10. Casey JL, Hentze MW, Koeller DM, et al. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science. 1988;240: 924-928.
11. Broxmeyer HE, Cooper S, Levi S, Arosio P. Mutuated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function. Proc Natl Acad Sci USA. 1991;88:770-774. (Pubitemid 21916105)
12. Yang X, Chen-Barrett Y, Arosio P, Chasteen ND. Reaction paths of iron oxidation and hydrolysis in horse spleen and recombinant human ferritins. Biochemistry. 1998;37:9743-9750. (Pubitemid 28319619)
13. Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radicals Biol Med. 2001;31:509-519. (Pubitemid 32728438)
14. Buckwalter JA, Glimcher MJ, Cooper RR, Recker R. Bone biology. I: Structure, blood supply, cells, matrix, and mineralization. Instr Course Lect. 1996;45:371-386.
15. Buckwalter JA, Glimcher MJ, Cooper RR, Recker R. Bone biology. II: Formation, form, modeling, remodeling, and regulation of cell function. Instr Course Lect. 1996;45:387-399.
16. Baslé MF, Mauras Y, Audran M, Clochon P, Rebel A, Allain P. Concentration of bone elements in osteoporosis. J Bone Miner Res. 1990;5:41-47.
17. Diamond T, Pojer R, Stiel D, Alfrey A, Posen S. Does iron affect osteoblast function? Studies in vitro and in patients with chronic liver disease. Calcif Tissue Int. 1991;48:373-379.
18. Duquenne M, Rohmer V, Legrand E, et al. Spontaneous multiple vertebral fractures revealed primary haemochromatosis. Osteoporosis Int. 1996;6:338-340. (Pubitemid 26280831)
19. Sinigaglia L, Fargion S, Fracanzani AL, et al. Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol. 1997;24:1809-1813. (Pubitemid 27394522)
20. Van de Vyver FL, Vanheule AA, Majelyne WM, et al. Serum ferritin as a guide for iron stores in chronic hemodialysis patients. Kidney Int. 1984;26:451-458. (Pubitemid 15224588)
21. de Vernejoul MC, Pointillart A, Golenzer CC, et al. Effects of iron overload on bone remodeling in pigs. Am J Pathol. 1984;116:377-384. (Pubitemid 14034003)
22. Matsushima S, Hoshimoto M, Torii M, Ozaki K, Narama I. Iron lactate - induced osteopenia in male Sprague-Dawley rats. Toxicol Pathol. 2001;29:623-629. (Pubitemid 34032641)
23. Cornish J, Callon KE, Naot D, et al. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology. 2004;145:4366-4374. (Pubitemid 39120586)
24. Naot D, Grey A, Reid IR, Cornish J. Lactoferrin: a novel bone growth factor. Clin Med Res. 2005;3:93-101.
25. Chen CH, Ho ML, Chang JK, Hung SH, Wang GJ. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporosis Int. 2005;16:2039-2045.
26. Christoforidis A, Kazantzidou E, Tsatra I, et al. Normal lumbar bone mineral density in optimally treated children and young adolescents with beta-thalassaemia major. Hormones. 2007;6:334-340.
27. Tyler PA, Madani G, Chaudhuri R, Wilson LF, Dick EA. The radiological appearances of thalassaemia. Clin Radiol. 2006;61:40-52.
28. Rioja L, Girot R, Garabédian M, Cournot-Witmer G. Bone disease in children with homozygous beta-thalassemia. Bone Miner. 1990;8:69-86. (Pubitemid 20010636)
29. Vogiatzi MG, Autio KA, Mait JE, Schneider R, Lesser M, Giardina PJ. Low bone mineral density in adolescents with beta-thalassemia. Ann NY Acad Sci. 2005;1054:462-466. (Pubitemid 43031057)
30. Brill PW, Winchester P, Giardina PJ, Cunningham-Rundles S. Deferoxamine-induced bone dysplasia in patients with thalassemia major. AJR, Am J Roentgenol. 1991;156:561-565.
31. Balla G, Jacob HS, Balla J, et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem. 1992;267:18148-18153.
32. Beazley KE, Nurminskaya M, Talbot CJ, Linsenmayer TF. Corneal epithelial nuclear ferritin: developmental regulation of ferritin and its nuclear transporter ferritoid. Dev Dyn. 2008;237:2529-2541.
33. Surguladze N, Patton S, Cozzi A, Fried MG, Connor JR. Characterization of nuclear ferritin and mechanism of translocation. Biochem J. 2005;388:731-740. (Pubitemid 40941558)
34. Thompson KJ, Fried MG, Ye Z, Boyer P, Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci. 2002;5:2165-2177. (Pubitemid 34746382)
35. Broyles RH, Belegu V, DeWitt CR, et al. Specific repression of beta-globin promoter activity by nuclear ferritin. Proc Natl Acad Sci USA. 2001;98:9145-9150. (Pubitemid 32743883)
36. Zhao G, Arosio P, Chasteen ND. Iron(II) and hydrogen peroxide detoxification by human H-chain ferritin: an EPR spin-trapping study. Biochemistry. 2006;45: 3429-3436. (Pubitemid 43376362)
37. Poole LB, Nelson KJ. Discovering mechanisms of signaling-mediated cysteine oxidation. Curr Opin Chem Biol. 2008;12:18-24.
38. Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. Arterioscler Thromb Vasc Biol. 1997;17:680-687.
39. Byon CH, Javed A, Dai Q, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem. 2008;283:15319-15327.
40. Zarjou A, Jeney V, Arosio P, et al. Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol. 2009;20: 1254-1263.